Back
Astellas Pharma Quote, Financials, Valuation and Earnings
AI DIVIDENDS: No. 1 Way to Collect Passive Income
Click here to get it for free.
Buy
51
ALPMY
Astellas Pharma
Last Price:
11.68
Seasonality Move:
0.97%
7 Day Trial
ALL ACCESS PASS
$
7
"If I Had To Start Again..." Expert Reveals #1 Investing Hack
In his latest free guide, Duffy reveals... click here to continue reading...Astellas Pharma Price Quote
$11.68
Astellas Pharma Key Stats
Buy
51
Astellas Pharma (ALPMY)
is a Buy
Day range:
$11.26 - $12.00
52-week range:
$9.15 - $13.14
Dividend yield:
3.94%
P/E ratio:
177.98
P/S ratio:
1.84
P/B ratio:
1.98%
Volume:
44.5K
Avg. volume:
73.4K
1-year change:
-7.96%
Market cap:
$20.9B
Revenue:
$11.1B
EPS:
$0.06
How Much Does Astellas Pharma Make?
-
How Much Are Astellas Pharma's Sales Annually?
ALPMY Revenues are $11.1B -
How Much Profit Does Astellas Pharma's Make A Year?
ALPMY net income is $118.1M
Is Astellas Pharma Growing As A Company?
-
What Is Astellas Pharma's Growth Rate Quarterly?
Quarterly YoY revenue growth is 0.11% -
What Is Astellas Pharma's EPS Quarterly YoY Growth Rate?
Quarterly, year-over-year diluted EPS growth rate is 0%
Astellas Pharma Stock Price Performance
-
Did Astellas Pharma Stock Go Up Last Month?
Astellas Pharma share price went up by 2.01% last month -
Did ALPMY's Share Price Rise Over The Last Year?
ALPMY share price fell by -7.96% over the past 1 year
What Is Astellas Pharma 52-Week High & Low?
-
What Is Astellas Pharma’s 52-Week High Share Price?
Astellas Pharma has traded as high as $13.14 over the past 52 weeks -
What Is Astellas Pharma’s 52-Week Low Share Price?
Astellas Pharma has traded as low as $9.15 over the past 52 weeks
Astellas Pharma Price To Free Cash Flow
Data Unavailable
Is It Risky To Buy Astellas Pharma?
-
How Much Debt Does Astellas Pharma Have?
Total long term debt quarterly is $0 -
How Much Cash Does Astellas Pharma Have?
Cash and short term investments quarterly total is $2.4B -
What Is Astellas Pharma’s Book Value Per Share?
Book value per share is 5.88
Is Astellas Pharma Cash Flow Positive?
-
What Is ALPMY Cash Flow From Operations?
Cash flow from operations (TTM) is $1.2B -
What Is Astellas Pharma’s Cash Flow From Financing?
Cash flow from financing (TTM) is $4.3B -
What Is Astellas Pharma’s Cash Flow From Investing?
Cash flow from investing (TTM) is -$5.9B
Astellas Pharma Return On Invested Capital
-
Is Management Doing A Good Job?
ALPMY return on invested capital is 0.66% -
What Is Astellas Pharma Return On Assets?
ROA measures how assets are converting to revenues and is 0.47% -
What Is ALPMY Return On Equity?
ROE is a measure of profitability and is 0.97%
Astellas Pharma Earnings Date & Stock Price
-
What Is Astellas Pharma's Stock Price Today?
A single share of ALPMY can be purchased today for 11.68 -
What Is Astellas Pharma’s Stock Symbol?
Astellas Pharma trades on the otcm under the ticker symbol: ALPMY -
When Is Astellas Pharma’s Next Earnings Date?
The next quarterly earnings date for Astellas Pharma is scheduled on November 1, 2024 -
When Is ALPMY's next ex-dividend date?
Astellas Pharma's next ex-dividend date is March 27, 2024 -
How To Buy Astellas Pharma Stock?
You can buy Astellas Pharma shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
Astellas Pharma Competitors
-
Who Are Astellas Pharma's Competitors?
Below is a list of companies who compete with Astellas Pharma or are related in some way:
Astellas Pharma Dividend Yield
-
What Is ALPMY Dividend Yield?
Astellas Pharma’s dividend yield currently is 3.94% -
What Is Astellas Pharma’s Payout Ratio?
Astellas Pharma’s payout ratio is 395.08% -
When Did Astellas Pharma Last Pay A Dividend?
The latest dividend pay date is November 1, 2024 -
What Is Astellas Pharma’s Dividend Per Share?
Astellas Pharma pays a dividend of $0.00 per share
Astellas Pharma Analyst Estimates
| YoY Growth | Past Surprise | |
|---|---|---|
| EPS: | 0.07% | 0% |
| Revenue: | 11.06% | 0% |
Analyst Recommendations
| Buy Recommendations: | 0 |
|---|---|
| Hold Recommendations: | 0 |
| Sell Recommendations: | 0 |
| Price Target: | 0.00 |
| Downside from Last Price: | -100% |